Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-ITGB6 Antibody (R1Q89)

Catalog #:   RHD29901 Specific References (24) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IP, WB
Accession: P18564
Overview

Catalog No.

RHD29901

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IP: 1:20, WB: 1:500-1:1000

Target

ITGB6, Integrin beta-6

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P18564

Applications

IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1Q89

Data Image
  • Western blot
    Western blot analysis of ITGB6 in rat Brain, C6, 3T3, Hela lysates using Integrin beta 6 antibody.
References

Integrin β6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin., PMID:40488391

ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4+ macrophage infiltration., PMID:39152118

Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis., PMID:37160775

Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer., PMID:35131862

A SMYD3/ITGB6/TGFβ1 Positive Feedback Loop Promotes the Invasion and Adhesion of Ovarian Cancer Spheroids., PMID:34621667

Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer., PMID:34200100

Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer., PMID:33838601

A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations., PMID:30696911

Initiation of fibrosis in the integrin Αvβ6 knockout mice., PMID:30500364

Systemic inhibition of BMP1-3 decreases progression of CCl4-induced liver fibrosis in rats., PMID:29482391

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density., PMID:29444691

ITGAV (alpha v integrins) bind SPP1 (osteopontin) to support trophoblast cell adhesion., PMID:28250242

Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion., PMID:26359297

A genome-wide association study for clinical mastitis in first parity US Holstein cows using single-step approach and genomic matrix re-weighting procedure., PMID:25658712

Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma., PMID:25549721

Therapeutic targeting of integrin αvβ6 in breast cancer., PMID:24974129

Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis., PMID:24167080

Functional characterization of a porcine emphysema model., PMID:24043489

Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor., PMID:23399898

Kidney transplants with progressing chronic diseases express high levels of acute kidney injury transcripts., PMID:23356967

Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice., PMID:19118215

Phenotypic and genetic characterization of a novel phenotype in pigs characterized by juvenile hairlessness and age dependent emphysema., PMID:18549483

Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis., PMID:17916808

Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury., PMID:16710477

Datasheet

Document Download

Anti-ITGB6 Antibody (R1Q89).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-ITGB6 Antibody (R1Q89) [RHD29901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only